Cardiovascular Systems (NASDAQ:CSII) and Becton, Dickinson and (NYSE:BDX) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, risk, institutional ownership, analyst recommendations, earnings, profitability and dividends.
Institutional and Insider Ownership
85.5% of Cardiovascular Systems shares are owned by institutional investors. Comparatively, 74.4% of Becton, Dickinson and shares are owned by institutional investors. 3.0% of Cardiovascular Systems shares are owned by company insiders. Comparatively, 0.1% of Becton, Dickinson and shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
Profitability
This table compares Cardiovascular Systems and Becton, Dickinson and's net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets |
|---|
| Cardiovascular Systems | -10.12% | -11.43% | -8.36% |
| Becton, Dickinson and | 5.11% | 13.30% | 5.60% |
Analyst Recommendations
This is a breakdown of current ratings and recommmendations for Cardiovascular Systems and Becton, Dickinson and, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score |
|---|
| Cardiovascular Systems | 0 | 0 | 7 | 0 | 3.00 |
| Becton, Dickinson and | 0 | 7 | 7 | 1 | 2.60 |
Cardiovascular Systems presently has a consensus price target of $45.5714, suggesting a potential upside of 30.58%. Becton, Dickinson and has a consensus price target of $280.2857, suggesting a potential upside of 22.67%. Given Cardiovascular Systems' stronger consensus rating and higher probable upside, analysts plainly believe Cardiovascular Systems is more favorable than Becton, Dickinson and.
Earnings & Valuation
This table compares Cardiovascular Systems and Becton, Dickinson and's top-line revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio |
|---|
| Cardiovascular Systems | $236.54 million | 5.92 | $-27,240,000.00 | ($0.79) | -44.18 |
| Becton, Dickinson and | $17.12 billion | 3.87 | $874 million | $10.20 | 22.40 |
Becton, Dickinson and has higher revenue and earnings than Cardiovascular Systems. Cardiovascular Systems is trading at a lower price-to-earnings ratio than Becton, Dickinson and, indicating that it is currently the more affordable of the two stocks.
Risk & Volatility
Cardiovascular Systems has a beta of 1.3, indicating that its stock price is 30% more volatile than the S&P 500. Comparatively, Becton, Dickinson and has a beta of 0.83, indicating that its stock price is 17% less volatile than the S&P 500.
Summary
Becton, Dickinson and beats Cardiovascular Systems on 8 of the 14 factors compared between the two stocks.
